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Liver X receptor-a and -b are members of the
nuclear hormone receptor superfamily that hetero-
dimerize with retinoid X receptor and are activated
by oxysterols. In recent studies we found that treat-
ment of cultured human keratinocytes with oxysterol-
stimulated differentiation, as demonstrated by
increased expression of involucrin and transglut-
aminase, and inhibited proliferation. The aims of
this study were to determine: (i) whether oxysterols
applied topically to the skin of mice induce differen-
tiation in normal epidermis; (ii) whether this effect
is mediated via liver X receptor-a and/or liver X
receptor-b; and (iii) whether oxysterols normalize
epidermal morphology in an animal model of epi-
dermal hyperplasia. Topical treatment of normal
hairless mice with 22(R)-hydroxycholesterol or
24(S),25-epoxycholesterol resulted in a decrease in
epidermal thickness and a decrease in keratinocyte
proliferation assayed by proliferating cell nuclear
antigen staining. Moreover, oxysterol treatment
increased the levels of involucrin, loricrin, and
pro®laggrin protein and mRNA in the epidermis,
indicating that oxysterols stimulate epidermal differ-
entiation. Additionally, topical oxysterol pretreat-
ment improved permeability barrier homeostasis.
Whereas liver X receptor-a±/± mice revealed no
alterations in epidermal differentiation, the epider-
mis was thinner in liver X receptor-b±/± mice than
in wild-type mice, with a reduced number of prolif-
erating cell nuclear antigen positive cells and a
modest reduction in the expression of differentiation
markers. Topical oxysterol treatment induced differ-
entiation in liver X receptor-a±/± mice whereas in
liver X receptor-b±/± mice there was no increase in
the expression of differentiation markers. Whereas
both liver X receptor-a and liver X receptor-b are
expressed in cultured human keratinocytes and in
fetal rat skin, only liver X receptor-b was observed
on northern blotting in adult mouse epidermis.
Finally, treatment of hyperproliferative epidermis
with oxysterols restored epidermal homeostasis.
These studies demonstrate that epidermal differenti-
ation is regulated by liver X receptor-b and that
oxysterols, acting via liver X receptor-b, can induce
differentiation and inhibit proliferation in vivo. The
ability of oxysterols to reverse epidermal hyperplasia
suggests that these agents could be bene®cial for the
treatment of skin disorders associated with hyper-
proliferation and/or altered differentiation. Key
words: keratinocytes/proliferation/permeability barrier/lori-
crin/involucrin. J Invest Dermatol 118:25±34, 2002
E
pidermal differentiation is required for the formation of
the stratum corneum that provides both the mechanical
and permeability barrier between the external environ-
ment and the internal milieu (Fuchs, 1990; Jackson et al,
1993; Eckert et al, 1997). The permeability barrier,
which is essential for terrestrial life, is sustained by extracellular,
lipid-enriched lamellar membranes in the stratum corneum. These
extracellular lipid-enriched lamellar membranes inhibit water and
aqueous solute movement (Elias and Menon, 1991; Jackson et al,
1993). Corneocytes in the stratum corneum are postmitotic,
terminally differentiated, anuclear keratinocytes with a rigid
corni®ed envelope that provides the extraordinary mechanical
strength to the stratum corneum (Reichert et al, 1993; Steinert,
1995). The corni®ed envelope is formed by extensive, covalent
cross-linking of involucrin, loricrin, and other proteins (Steinert
and Marenkov, 1995, 1997). These proteins are expressed in a
spatially and temporally regulated pattern as suprabasal keratinocytes
undergo terminal differentiation during their upward migration
towards the surface of the epidermis, and therefore, they serve as
markers of the differentiation process (Fuchs, 1990; Eckert et al,
1997). The cross-linking of these proteins is catalyzed by the
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keratinocyte-speci®c enzyme, transglutaminase I, which is also
expressed late in keratinocyte differentiation (Fuchs, 1990; Steinert
and Marenkov, 1995, 1997; Eckert et al, 1997). The viable
precursors of corneocytes are the terminally differentiated keratino-
cytes of the stratum granulosum, which are characterized by the
presence of keratohyalin granules, containing pro®laggrin and
loricrin as well as numerous lipid-containing lamellar bodies
(Fuchs, 1990; Elias and Menon, 1991; Jackson et al, 1993; Eckert
et al, 1997). The proliferation rate of cells in the basal layer is
balanced by the rates of apoptosis and corneocyte formation in the
outer epidermis (Fuchs, 1990; Eckert et al, 1997). Despite the
importance of keratinocyte differentiation for epidermal function,
the factors that regulate keratinocyte differentiation are not well
understood (Fuchs, 1990; Eckert et al, 1997).
Nuclear hormone receptors are transcription factors that regulate
many cellular functions, including cellular differentiation
(Mangelsdorf et al, 1995; Kliewer et al, 1999). The nuclear receptor
superfamily has been divided into four major subgroups according
to their dimerization and DNA binding properties (Mangelsdorf
et al, 1995). The class II subfamily consists of nuclear receptors that
heterodimerize with retinoid X receptor (RXR). Members of this
subfamily usually bind to direct repeats separated by a variable
number of spacer nucleotides (Mangelsdorf et al, 1995). Stimulation
of several of the receptors in this subgroup, including the retinoic
acid activated receptor (RAR), vitamin D receptor, and peroxi-
some proliferator activated receptor (PPAR)-a, regulates keratino-
cyte proliferation and differentiation (Bikle, 1996; Eichner et al,
1996; Fisher and Voorhees, 1996; Kang et al, 1996; Hanley et al,
1998; KoÈmuÈves et al, 2000a,b). Moreover, keratinocyte differen-
tiation is abnormal in transgenic mice that overexpress RAR or
RXR dominant negative mutations in the epidermis, further
showing the importance of nuclear hormone receptors that
heterodimerize with RXR (Imakado et al, 1995; Saitou et al,
1995; Feng et al, 1997). Additionally, in mice with a de®ciency of
RXR-a localized to the epidermis, epidermal hyperplasia occurs
suggesting keratinocyte hyperproliferation, which is consistent with
the inhibition of proliferation observed with vitamin D and PPAR-
a ligands (Li et al, 2000).
Recently, we have shown that liver X receptor (LXR) -a and
LXR-b are expressed in cultured human keratinocytes and in fetal
rat epidermis (Hanley et al, 1999, 2000). Moreover, we have
demonstrated that certain oxysterol ligands for LXR increased
corni®ed envelope formation, as well as the levels of involucrin and
transglutaminase protein and mRNA in normal human keratino-
cytes, indicating that oxysterols stimulate keratinocyte differenti-
ation in vitro (Hanley et al, 2000). In contrast, oxysterols inhibited
DNA synthesis in vitro by approximately 50% (Hanley et al, 2000).
Lastly, we have shown that oxysterols accelerate the development
of the epidermis in fetal rats, accelerating the formation of the
cutaneous permeability barrier (Hanley et al, 1999).
The purpose of this study was to determine: (i) whether
oxysterols, known to be ligands for LXR ± 22(R)-hydroxycho-
lesterol (22(R)OHCHOL) and 24(S),25-epoxycholesterol
(24(S)25EPOCHOL) ± when applied topically to the skin of
mice induce differentiation in normal epidermis; (ii) whether this
effect is mediated via LXR-a and/or LXR-b; and (iii) whether
oxysterols normalize epidermal morphology in a hyperplastic
animal disease model.
MATERIALS AND METHODS
Animals and tissue preparation Adult hairless mice 6±10 wk of age
(Simonsen, Gilroy, CA or Charles River, Wilmington, MA) were
treated topically twice a day for 4 d with 22(R)OHCHOL (Sigma, St
Louis, MO) (500 nM, 200 mM, 500 mM dissolved in polypropylene
glycol±ethanol 3:1 or in ethanol; 0.1 ml applied to 2 cm2 area on one
¯ank). Moreover, 24(S)25EPOCHOL (a gift from Timothy Willson,
Nuclear Receptor Discovery Research, GlaxoSmithKline, Research
Triangle Park, NC) was applied to the ¯ank in a similar fashion as
22(R)OHChol (500 nM in polypropylene glycol±ethanol 3 : 1). Control
hairless mice were treated with vehicle alone in an identical fashion. The
experiments were done in triplicate.
LXR-a±/± (four adults), LXR-b±/± (four adults), and LXR-ab±/±
(three adults) de®cient mice were produced as described previously (Peet
et al, 1998). These ``knockout'' animals and age- and sex-matched
controls (LXR-ab+/+ adults) of the same genetic background were
gently shaved and then topically treated twice a day for 4 d with either
22(R)OHCHOL in ethanol, or with ethanol alone.
Epidermal hyperproliferation was induced in male hairless mice by
repeated barrier abrogation with acetone, twice a day, for 5 d, as
previously described (Denda et al, 1996). For an additional 4 d these
animals were treated topically with either 22(R)OHCHOL or vehicle as
described above.
Cutaneous permeability barrier function was determined by measuring
transepidermal water loss (TEWL) with a Meeco electrolytic water
analyzer, as described previously (KoÈmuÈves et al, 2000a,b). Barrier repair
was measured by ®rst disrupting the barrier by repetitive, gentle wipes
with acetone or by repetitive tape stripping with cellophane tape until
the TEWL levels were 3±7 mg per cm2 per h, and then determining
TEWL at 3, 6, 16, and 24 h as an index of barrier homeostasis
(KoÈmuÈves et al, 2000a,b).
Skin samples were ®xed overnight in 4% formaldehyde (freshly
prepared from paraformaldehyde (Sigma) and embedded in paraf®n
(ParaplastPlus, Fisher Scienti®c, Pittsburgh, PA). Sections (5 mm for
immunohistochemistry, 15 mm for in situ hybridization) were collected
on SuperfrostPlus slides (Fisher Scienti®c), and processed as described
below.
Immunohistochemistry Af®nity-puri®ed rabbit antibodies, speci®c
for involucrin, pro®laggrin/®laggrin, and loricrin (Covance/BabCo,
Berkeley, CA), and a biotinylated monoclonal anti-proliferating cell
nuclear antigen (anti-PCNA) antibody (CalTag Laboratories, Burlingame,
CA) were used. Af®nity-puri®ed biotinylated goat anti-rabbit IgG,
af®nity-puri®ed biotinylated goat anti-mouse IgG, and ABC-peroxidase
(ABC-PO) were purchased from Vector (Burlingame, CA). Immuno-
histochemical localization of these proteins was performed as described
previously (KoÈmuÈves et al, 1998, 2000a,b), and peroxidase activity was
revealed with diaminobenzidine (Vector). For the detection of PCNA
proteins, antigen retrieval was performed with microwave treatment in
10 mM citrate buffer, pH = 6.0. Omission of the ®rst antibodies, or
incubation with the substrate solution resulted in no signal, showing that
nonspeci®c binding of the second antibody and/or ABC-PO, or
endogenous peroxidase activity were not contributing to the signals
obtained.
In situ hybridization Biotin-labeled RNA probes to detect loricrin
and pro®laggrin mRNA were synthesized from linearized cDNA
sequences (a gift from S. Yuspa, NIH), using reagents supplied by Roche
Molecular Biochemicals (Indianapolis, IN). In situ hybridization was
performed as described previously (KoÈmuÈves et al, 2000a), with the
following modi®cations. The sections were hybridized at 45°C and the
hybridization of the biotin-labeled probes to endogenous mRNA was
detected with ABC-PO (Vector). Biotinylated tyramide (CSA kit,
DAKO, Carpinteria, CA) was used for signal ampli®cation, followed
by incubation with ABC-alkaline phosphatase (Vector). Alkaline
phosphatase activity was developed with VectorRed substrate (Vector).
Hybridization with biotin-labeled, sense control probes resulted in no
signal, indicating the speci®city of hybridization with the anti-sense
probes. Omitting the biotin-labeled anti-sense probes from the
hybridization cocktail resulted in no signal, which demonstrated that
only biotin-containing RNA hybrids were detected. Moreover,
incubation with the BCIP/NTBT substrate reagents alone resulted in no
staining, showing that endogenous alkaline phosphatase activity within
the tissues did not contribute to the signal obtained.
Microscopy and imaging The tissue samples were analyzed with an
Olympus BX50 microscope using 20 3 UplanApo and 40 3 UplanFl
objectives with bright-®eld or differential interference±contrast (DIC)
illumination. Images were acquired with a DEI 750 CCD camera
(Optronics, Goleta, CA), controlled by BioQuant Nova imaging
software (R&M Biometrics, Nashville, TN). The digitized images were
resized to 300 dpi resolution and assembled using Photoshop 5.5 (Adobe
Systems, Mountain View, CA). Apart from adjusting the background
intensities (using the Level tool in Photoshop), and cropping to size, no
other digital tools were applied to the images. The ®gures were printed
with Epson Stylus Photo 870 inkjet printer. Epidermal thickness was
determined using a computer-generated micrometer (Carl Zeiss Vision,
Munich, Germany). Epidermal thickness was de®ned as the distance
between the basement lamina and the stratum granulosum±stratum
26 KOÈ MUÈ VES ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
corneum interface. Epidermal proliferation was determined by
quantitating PCNA positive nuclei in the basal layer of the epidermis per
unit length of basement membrane.
Northern blotting To separate whole epidermis from full thickness
skin, skin was placed in 10 mM ethylenediamine tetraacetic acid in
calcium-free and magnesium-free phosphate-buffered saline, pH 7.4, for
35 min at 37°C. The epidermis was removed by scraping with a scalpel
blade. RNA from epidermis and liver was prepared by a variation of the
guanidinium thiocyanate method, as described previously (Jackson et al,
1992). Total RNA was puri®ed and added to oligo(dT)-cellulose to
obtain poly(A)+ RNA. Northern blots were prepared as described
previously (Jackson et al, 1992).
RESULTS
Oxysterols induce epidermal differentiation We ®rst asked
whether oxysterols induce keratinocyte differentiation in intact
mice, as previously shown in cultured keratinocytes (Hanley et al,
2000). Topical applications of several concentrations (500 nm,
200 mM, 500 mM) of 22(R)OHCHOL (Fig 1), or 500 nm
24(S)25EPOCHOL (not shown) for 4 d resulted in a decrease in
epidermal thickness as compared with vehicle-treated controls
(Fig 1, oxysterol 10.97 6 0.69 mm, one to two epidermal cell
layers vs vehicle 20.19 6 0.49 mm, p < 0.001, three to four
epidermal cell layers). Moreover, these treatments also resulted in a
decrease in the proliferative pool of epidermal keratinocytes, as
assayed by PCNA immunostaining (oxysterol 13.2% PCNA
positive nuclei per unit length of basement membrane vs vehicle
32.8%, p < 0.001). The occasional suprabasal, PCNA-positive cells
that occur in vehicle-treated epidermis (Fig 1C) were completely
eliminated by oxysterol treatments (Fig 1D).
On the other hand, involucrin, ®laggrin, and loricrin protein
levels all increased in oxysterol-treated epidermis (Fig 2). Whereas
we observed increased labeling with the respective antibodies,
staining remained restricted to the granular and upper spinous
epidermal cell layers. The changes were especially pronounced for
involucrin (Fig 2A vs 2B,C) and pro®laggrin/®laggrin (Fig 2D vs
2E, F), but were less evident with loricin, perhaps because of its
restricted localization to the stratum granulosum (Fig 2G vs 2H, I).
Moreover, pro®laggrin (Fig 3A vs 3B, C) and loricrin (Fig 3D vs
3E, F) mRNA levels increased following oxysterol treatment,
suggesting that the increase in the protein markers of differentiation
was due to increased mRNA levels. Thus, topical 22(R)OHCHOL
or 24(S)25EPOCHOL treatments induce the differentiation of
epidermal keratinocytes. None of these epidermal changes were
observed on the contralateral side or outside of the treated area (not
shown). Therefore, the observed changes re¯ect a direct, local
action of the oxysterols tested, rather than a secondary, systemic
effect of these compounds. Taken together, these results clearly
establish that, as in cultured human keratinocytes, oxysterols can
modulate and upregulate epidermal differentiation in vivo in murine
skin.
Pretreatment with oxysterols accelerates barrier repair The
end product of epidermal differentiation is the provision of the
cutaneous permeability barrier (Elias and Menon, 1991; Jackson
et al, 1993). We previously demonstrated that oxysterols stimulate
in utero development of the permeability barrier in fetal skin
(Hanley et al, 1999). Therefore, we next determined the effects of
topical oxysterols on permeability barrier homeostasis in adult
mice. We observed no differences in basal TEWL following
repeated oxysterol treatment; however, sites pretreated with
22(R)OHCHOL for 3 d demonstrated accelerated barrier repair
kinetics compared with vehicle-treated sites after barrier disruption
with either acetone or tape stripping (Fig 4). Thus, topical
oxysterol treatment improves barrier homeostasis in adult mice.
Keratinocyte differentiation is impaired in LXR-b de®cient
mice Whereas these experiments indicate that oxysterols are
capable of regulating epidermal keratinocyte differentiation and
barrier homeostasis following topical treatment, they do not
distinguish between receptor-speci®c vs unrelated mechanisms.
Therefore, we next determined whether the absence of either of
the two LXR receptors would impair epidermal keratinocyte
differentiation. The morphologic appearance of the epidermis
(Fig 5A vs 5C); localization of involucrin (Fig 6A vs 6C), ®laggrin
(Fig 7A vs 7C), and loricrin (Fig 7G vs 7I) proteins; and ®nally,
the expression of pro®laggrin (Fig 8A vs 8C) and loricrin (Fig 8G
vs 8I) mRNA were indistinguishable in LXR-a±/± mice vs wild-
type (LXR-ab+/+) mice. These ®ndings indicate that the absence
of LXR-a does not affect keratinocyte terminal differentiation
in vivo. In contrast, in either LXR-b±/± (Fig 5B, 21.42 6 1.17 mm,
one to two epidermal cell layers) or LXR-ab±/± mice (not shown)
the epidermis was thinner than in wild-type skin (Fig 5A,
35.81 6 2.13 mm, p < 0.001, two to three epidermal cell layers)
with a reduced number of PCNA-positive cells in the basal layer
(Fig 5E, 7.6% per unit length of basement membrane in b±/± vs
16% in a±/± vs 23.6% in wild type, p < 0.001). Moreover, the
expression of differentiation markers at both the protein and
mRNA levels was slightly reduced in LXR-b±/± mice in
comparison with wild-type mice (Figs 6 and 7). These
observations suggest that signaling via LXR-b regulates the
differentiation of normal epidermis; however, the absence of
major cutaneous abnormalities in LXR-b±/± or LXR-ab±/±
Figure 1. Effects of topical oxysterol
treatment on epidermal morphology. Hairless
mouse skin was treated for 4 d, twice a day with
22(R)OHCHOL (B, D). Control animals were
treated with vehicle (A, C). Hematoxylin±eosin-
stained sections showed a decrease in the thickness
of the epidermis (A vs B). Immunohistochemical
detection of PCNA (a protein expressed in
cycling cells) revealed a decrease in proliferating
cell number in the epidermis of 22(R)OHCHOL-
treated animals (D) as compared with the control
(C). A, B: bright-®eld illumination, C, D: DIC
illumination. Scale bar: 50 mm.
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knockout mice indicates that LXR-b may be only one of several
factors that regulate epidermal differentiation, and that in its
absence other pathways can compensate, maintaining the basic
organization of the epidermis. Likewise, barrier recovery studies
did not show any difference between wild-type and knockout mice
(data not shown), indicating that the morphologic abnormalities do
not result in functional impairment.
The effects of oxysterols on epidermal differentiation are
mediated by LXR-b To determine whether oxysterols induce
differentiation by speci®cally activating LXR, we initially
determined the effects of topical treatment with 22(R)OHCHOL
for 4 d in mice de®cient both in LXR-a and LXR-b (LXR-ab±/±
double knockout mice). As seen above in hairless mice, in the wild-
type (LXR-ab+/+) mice oxysterol treatment increased the
Figure 3. Effects of topical oxysterol
treatment on the expression of pro®laggrin
and loricrin mRNA. Hairless mouse skin was
treated for 4 d, twice a day with 22(R)OHCHOL
(B, E) or 24(S)25EPOCHOL (C, F). Control
animals were treated with vehicle (A, D).
Pro®laggrin and loricrin mRNA were localized
with speci®c, biotin-labeled anti-sense riboprobes
(red signal). Notice the prominent increase in
pro®laggrin (B, C) and loricrin (E, F) staining
following treatment with 22(R)OHCHOL (B, E)
or 24(S)25EPOCHOL (C, F) as compared with
the control (A, D). A±F: DIC illumination. Scale
bar: 50 mm.
Figure 2. Effects of topical oxysterol treatment on the localization of involucrin, ®laggrin, and loricrin proteins. Hairless mouse skin was
treated for 4 d, twice a day with 22(R)OHCHOL (B, E, H) or 24(S)25EPOCHOL (C, F, I). Control animals were treated with vehicle (A, D, G).
Involucrin, ®laggrin, and loricrin proteins were detected with speci®c af®nity-puri®ed rabbit antibodies followed by goat biotinylated anti-rabbit IgG
and ABC-PO. Peroxidase activity was revealed with diaminobenzidine substrate. Notice the prominent increase in involucrin (B, C) and ®laggrin (E,
F) staining in 22(R)OHCHOL (B, E) or 24(S)25EPOCHOL (C, F) treated animals as compared with the control (A, D). Scale bar: 50 mm.
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expression of differentiation markers, including involucrin,
pro®laggrin/®laggrin, and loricrin (Figs 6±8); however, in
genetically matched LXR-ab±/± double knockout mice, de®cient
in both LXR-a and -b, there were no changes in the levels of these
differentiation markers (data not shown). These results indicate that
the oxysterol induction of differentiation is mediated by LXR-a
and/or LXR-b.
To determine whether LXR-a and/or LXR-b is important in
mediating these effects, we next examined the effects of topical
oxysterols in LXR-a±/± or LXR-b±/± de®cient mice (single
knockout mice). In LXR-a±/± mice topical 22(R)OHCHOL for
4 d induced an increase in involucrin (Fig 6C vs 6F), ®laggrin
(Fig 7C vs 7F), and loricrin (Fig 7I vs 7L) immunoreactivity,
similar to that observed in wild-type (LXR-ab+/+) mice. Again
immunolabeling was restricted to the granular and upper spinous
cell layers. The changes induced by topical oxysterol application in
LXR-a±/± as well as in wild-type (LXR-ab+/+) epidermis, were
even more pronounced for pro®laggrin (Fig 8A vs 8D, and 8C vs
8F) and loricrin (Fig 8G vs 8J, and 8I vs 8L) mRNA expression.
These results indicate that LXR-a is not required for the oxysterol
induction of epidermal differentiation.
In contrast, in LXR-b±/± mice topical 22(R)OHCHOL applic-
ation for 4 d failed to increase expression of epidermal differen-
tiation markers, including involucrin (Fig 6B vs 6E), ®laggrin
(Fig 7B vs 7E), and loricrin (Fig 7H vs 7K). The lack of response
to topical oxysterol treatment in the epidermis of LXR-b±/± mice
was even more apparent when pro®laggrin (Fig 8B vs 8E) and
loricrin mRNA levels (Fig 8H vs 8K) were compared by in situ
hybridization. These observations indicate that LXR-b is essential
for the oxysterol stimulation of epidermal keratinocyte differenti-
ation, and that LXR-a cannot compensate for the absence of
LXR-b.
LXR-b is the predominant LXR isoform in adult murine
epidermis Previous studies have demonstrated that both LXR-a
and LXR-b are expressed in human keratinocytes grown in culture
and in fetal rat epidermis (Hanley et al, 1999, 2000). As the
observations described above indicate that LXR-b is essential for
the oxysterol-induced epidermal differentiation, we next examined
if both LXR-a and LXR-b are expressed in adult mouse
epidermis. In contrast to human keratinocytes and fetal rat
epidermis, northern blotting demonstrated that LXR-b is the
predominant LXR isoform expressed in adult mouse epidermis
(Fig 9). The predominance of LXR-b in adult mouse epidermis is
consistent with our observations that the expression of
differentiation markers is modestly reduced in LXR-b±/± mice
and oxysterol-induced differentiation does not occur in mice
de®cient in LXR-b.
Oxysterols normalize epidermal homeostasis in hyper-
proliferative epidermis Finally, we tested the ability of
topical oxysterols to normalize epidermal morphology in a
murine model of repeated barrier abrogation, which is
characterized by epidermal hyperplasia and aberrant keratinocyte
differentiation (Denda et al, 1996; KoÈmuÈves et al, 2000b). When
22(R)OHCHOL was applied to hyperplastic epidermis, there was a
decrease in epidermal thickness in 22(R)OHCHOL-treated
animals, as compared with the vehicle-treated mice (Fig 10,
oxysterol 22.74 6 1.41 mm, two epidermal cell layers vs vehicle
38.64 6 1.87 mm, p < 0.0001, three to four epidermal cell layers).
Moreover, a prominent transitional cell layer appeared between the
stratum granulosum and stratum corneum (Fig 10B), indicative of
accelerated terminal differentiation, i.e., more rapid conversion of
nucleated keratinocytes into corneocytes. These observations
demonstrate that topical oxysterols can restore normal
morphology in hyperproliferative epidermis.
DISCUSSION
In this study, we demonstrate that the topical application of
22ROHChol and 24(S)25EPOCHOL, two oxysterols that activate
LXR, stimulate epidermal differentiation in vivo. Topical applica-
tion of oxysterols increased the expression of loricrin, ®laggrin, and
involucrin, proteins that are expressed in the outer epidermis and
are required for the formation of the corni®ed envelope and
keratohyalin granules. Thus, oxysterols stimulate the latter stages of
differentiation of keratinocytes in intact murine epidermis.
Moreover, treatment with oxysterols accelerates the ability of the
epidermis to restore cutaneous barrier function following barrier
disruption by tape stripping or acetone treatment. The cutaneous
permeability barrier is the end product of epidermal differentiation,
and thus it is a functional marker of epidermal differentiation.
Additionally, our studies further demonstrate that topical applica-
tion of oxysterols inhibits epidermal proliferation. These observa-
tions extend previous studies, where we demonstrated that
oxysterols stimulate differentiation and inhibit cell proliferation
when added to human keratinocytes in culture (Hanley et al, 2000).
With PPAR-a ligands, we and others have shown a similar
induction of differentiation and inhibition of proliferation in
keratinocytes both in vivo and in vitro (Hanley et al, 1998; Rivier et
al, 1998; KoÈmuÈves et al, 2000a). Pertinently, most studies with
retinoids or vitamin D have shown that these nuclear hormone
ligands display markedly different effects when applied topically to
animals as compared with their in vitro effects. Retinoids inhibit
Figure 4. Effects of topical oxysterol treatment on epidermal
permeability barrier homeostasis. Male hairless mice were treated
with vehicle or 22(R)OHCHOL twice a day for 4 d. Next the animals
were treated with acetone (A) or repeated tape stripping (B) until the
TEWL reached 6±8 mg per cm2 per h. TEWL was measured at 3, 6, 16,
and 24 h and recovery of barrier function is expressed as percentage of
time zero. Data are presented as mean 6 SEM.
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keratinocyte differentiation in vitro, while stimulating differentiation
when applied to intact animals (Brown et al, 1994; Eichner et al,
1996; Fisher and Voorhees, 1996; Kang et al, 1996; Hanley et al,
1998). Conversely, 1,25(OH)2-vitamin D3 inhibits proliferation
and stimulates differentiation in vitro, while stimulating proliferation
when applied in vivo (Pillai and Bikle, 1991; Bikle, 1996; Kang et al,
1996). In contrast, with both oxysterols and PPAR-a ligands, the
in vitro and in vivo effects on keratinocyte proliferation and
differentiation are identical (Hanley et al, 1998, 2000; KoÈmuÈves et
al, 2000a; this paper).
Figure 5. Effects of topical oxysterol treatment on epidermal morphology in LXR-b±/± and LXR-a±/± mice. Shaved skin of LXR-b±/± (B,
E, H), LXR-a±/± (C, F, I), and wild-type, control (LXR-ab+/+, A, D, G) mice were treated for 4 d, twice a day with 22(R)OHCHOL (G, H, I).
Hematoxylin±eosin-stained sections showed the epidermis of LXR-b±/± (B) animals was thinner as compared with wild-type control (LXR-ab+/+, A)
or LXR-a±/± (C) mice. Moreover, immunohistochemical detection of PCNA (a protein expressed in cycling cells) revealed a decrease in proliferating
cells in the epidermis of LXR-b±/± mice (E) compared with wild-type control (LXR-ab+/+) or LXR-a±/± mice (D, F). Topical 22(R)OHCHOL
treatment resulted in a decrease in epidermal thickness in wild-type (LXR-ab+/+) control (A vs G), and LXR-a±/± (C vs I) mice; however, the
epidermal thickness in LXR-b±/± mice remained unaffected (B vs H) following topical 22(R)OHCHOL treatment. A±C, G±I: bright-®eld
illumination, D±F: DIC illumination. Scale bar: 50 mm.
Figure 6. Effects of topical oxysterol treatment on involucrin localization in LXR-b±/± and LXR-a±/± mice. Shaved skin of LXR-b±/± (B,
E), LXR-a±/± (C, F), and wild-type control (LXR-ab+/+, A, D) mice were treated for 4 d, twice a day with 22(R)OHCHOL (D±F) or with vehicle
(A±C). Immunohistochemical detection of involucrin showed an increased staining in wild-type (LXR-ab+/+) control (A vs D) and LXR-a±/± (C vs
F) mice following 22(R)OHCHOL treatment; however, no such changes were seen in the epidermis of LXR-b±/± mice (B vs E). Scale bar: 50 mm.
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This study further demonstrates that the oxysterol induction of
differentiation in adult mouse epidermis is mediated via LXR-b,
the predominant LXR isoform expressed in adult murine epider-
mis. The expression of differentiation markers is reduced in mice
de®cient in LXR-b. Moreover, topical oxysterols do not induce
differentiation in LXR-b-de®cient mice, whereas oxysterols
induce differentiation in wild-type or LXR-a-de®cient mice.
Furthermore, LXR-a is either not expressed or expressed at low
levels in murine epidermis. Thus, LXR-b is essential for the
oxysterol stimulation of differentiation, and LXR-a cannot
compensate for the absence of LXR-b. These studies do not rule
out a role for LXR-a in the epidermis of species where it may be
expressed in greater abundance.
To our knowledge this is one of the ®rst examples of a biologic
response that is mediated exclusively by LXR-b. In the liver,
LXR-a is essential for the increase in cholesterol 7-a-hydroxylase
that occurs with cholesterol feeding, and the presence of LXR-b in
the liver of LXR-a-de®cient mice cannot compensate for the
absence of LXR-a (Peet et al, 1998). Recently, other genes
important for cholesterol metabolism have been shown to be
regulated by LXR. Speci®cally, the adenosine triphosphate-binding
cassette transporters, ABC1 and ABC8, which mediate the ef¯ux of
cholesterol out of cells, and cholesterol ester transfer protein, a
protein important in reverse cholesterol transport are stimulated by
the RXR/LXR heterodimer (Costat et al, 2000; Luo and Tall,
2000; Repa et al, 2000b; Venkateswaran et al, 2000). Furthermore,
very recent studies have shown that in addition to regulating
cholesterol metabolism, stimulation of LXR increases lipogenesis
by increasing the expression of the transcription factor SREBP-1c
(Repa et al, 2000a; Schultz et al, 2000). The present study
demonstrates that LXR stimulation plays a part in regulating
keratinocyte differentiation, a process that is not known to be
linked directly to lipid metabolism.
The mechanism by which activation of LXR-b stimulates the
expression of the proteins involved in keratinocyte differentiation
has been explored in our in vitro studies (Hanley et al, 2000). We
have demonstrated that oxysterols increase the levels of involucrin
mRNA when added to human keratinocytes, and that this increase
is due to an increase in transcription. Using a series of truncations
and deletions of the involucrin promoter upstream of a luciferase
reporter, we identi®ed an oxysterol-responsive region spanning
nucleotides ±2452 bp to ±1872 bp. A single base pair mutation of
the AP-1 site contained in this region (AP-1±5, ±2117 to
±2111 bp) abolished oxysterol responsiveness. Moreover, oxyster-
ols increase the expression of an AP-1 reporter construct transfected
into keratinocytes and gel shift experiments demonstrated increased
Figure 7. Effects of topical oxysterol treatment on ®laggrin and loricrin localization LXR-b±/± and LXR-a±/± mice. Shaved skin of
LXR-b±/± (B, E, H, K ), LXR-a±/± (C, F, I, L), and wild-type control (LXR-ab+/+, A, D, G, J ) mice were treated for 4 d, twice a day with
22(R)OHCHOL (D±F, J±L) or with vehicle (A±C, G±I). Immunohistochemical detection of ®laggrin (A±F ) and loricrin (G±L) showed an increased
staining in the epidermis of wild-type (LXR-ab+/+) control (A vs D, G vs J ), and LXR-a±/± (C vs F, I vs L) mice following 22(R)OHCHOL
treatment. On the contrary, both ®laggrin (B vs E) and loricrin (H vs K ) localization remained unchanged in the epidermis of LXR-b±/± mice. Scale
bar: 50 mm.
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binding of nuclear extracts from oxysterol-treated keratinocytes to
AP-1±5. Pertinently, this same AP-1±5 site mediates the increase in
involucrin expression stimulated by 12-O-tetradecanoyl-phorbol-
13-acetate, calcium, and PPAR-a ligands (Welter et al, 1995;
Banks et al, 1998; KoÈmuÈves et al, 2000a; Ng et al, 2000). As a
number of the other proteins that increase during keratinocyte
differentiation also are known to be regulated by AP-1 transcription
factors (Eckert et al, 1997), one can postulate that oxysterols act
through LXR-b to increase AP-1 activity thereby coordinately
stimulating the expression of a variety of proteins required for
keratinocyte differentiation.
As noted above, the expression of differentiation markers was
slightly reduced in untreated LXR-b- or LXR-ab-de®cient mice
compared with wild-type mice, suggesting that LXR-b plays a part
in regulating normal epidermal keratinocyte differentiation.
Paradoxically, given the decrease in epidermal thickness and
PCNA staining with oxysterol treatment of normal animals, in
LXR-b- and LXR-ab-de®cient mice the thickness of the
epidermis and PCNA staining was slightly reduced. The explan-
ation for this decrease is unclear but it is worth noting that in LXR-
a-de®cient mice basal levels of cholesterol 7-a hydroxylase in the
liver are increased despite an inability of oxysterols to further
increase expression (Peet et al, 1998). It is postulated that LXR-a
plus ligand stimulates the expression of cholesterol 7-a hydroxylase
but that LXR-a alone inhibits expression. In animals de®cient in
LXR-a basal expression of cholesterol 7-a hydroxylase is therefore
increased. Whether a similar phenomenon is occurring with regards
to keratinocyte proliferation is unknown. Notably, the gross
cutaneous phenotypes of LXR-b- and LXR-ab-de®cient mice are
normal indicating that multiple factors regulate epidermal develop-
ment and differentiation, and that the absence of LXR-b alone is
not suf®cient to result in substantial abnormalities in the epidermis.
It is likely that the activation of other nuclear hormone receptors,
such as PPAR-a and the vitamin D receptor, can compensate for
the absence of LXR-b.
Cholesterol synthesis is very active in the epidermis and large
quantities of cholesterol are required for the formation of lamellar
bodies (Feingold, 1991). Stress to the epidermis such as ultraviolet
light, air pollution, and aging increases the oxidative state of
keratinocytes thereby potentially increasing the formation of
oxysterols (Ozawa et al, 1991; Darr and Fridovich, 1994; Fuchs
et al, 1995; Yamazaki et al, 1999). Moreover, cholesterol is
Figure 8. Effects of topical oxysterol treatment on pro®laggrin and loricrin mRNA expression in LXR-b±/± and LXR-a±/± mice. Shaved
skin of LXR-b±/± (B, E, H, K), LXR-a±/± (C, F, I, L) and wild-type control (LXR-ab+/+, A, D, G, J) mice were treated for 4 d, twice a day with
22(R)OHCHOL (D±F, J±L) or with vehicle (A±C, G±I). In situ hybridization with anti-sense biotin-labeled riboprobes were used to localize
pro®laggrin (A±F) and loricrin (G±L) mRNA. Sense control riboprobes did not yield a signal under identical conditions. Both pro®laggrin and loricrin
anti-sense probes indicated an increased expression in the epidermis of wild-type (LXR-ab+/+) control (A vs D, G vs J), and LXR-a±/± (C vs F, I vs
L) mice following 22(R)OHCHOL treatment; however, neither pro®laggrin (B vs E) nor loricrin (H vs K) mRNA expression changed in the
epidermis of LXR-b±/± mice. A±L: DIC illumination. Scale bar: 50 mm.
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converted to oxysterols, some of which are LXR ligands, by P450
enzymes that are expressed in many tissues, including the epidermis
(Jugert et al, 1994; Russell, 2000). Although the levels of speci®c
oxysterols in the epidermis and keratinocytes are not yet known, it
is possible that oxysterols may serve as endogenous regulators of
keratinocyte differentiation and development. Finally, our studies
have also demonstrated that topical treatment with oxysterols can
normalize the epidermal hyperplasia seen after repeated barrier
disruption, suggesting that LXR ligands could be used therapeutic-
ally to treat a variety of skin disorders.
In conclusion, this study demonstrates that naturally occurring
oxysterols stimulate epidermal differentiation and that this effect is
mediated via LXR-b. It is possible that oxysterols may be clinically
useful for the treatment of cutaneous disorders due to impaired
differentiation and/or increased proliferation.
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